Sio Capital Management, LLC Affimed N.V. Transaction History

Sio Capital Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.27 - $4.86 $402,700 - $862,168	177,401 Added 27.56%	821,065 $2.27 Million
Q1 2022 May 16, 2022	BUY	$3.69 - $5.65 $2.38 Million - $3.64 Million	643,664 New	643,664 $2.81 Million
Q3 2021 Nov 15, 2021	SELL	$5.54 - $7.51 $3.96 Million - $5.37 Million	-714,576 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.78 - $11.4 $1.3 Million - $1.9 Million	166,532 Added 30.39%	714,576 $6.07 Million
Q1 2021 May 14, 2021	BUY	$5.12 - $8.48 $2.81 Million - $4.65 Million	548,044 New	548,044 $4.34 Million
Q4 2020 Feb 16, 2021	SELL	$3.16 - $7.03 $2.88 Million - $6.41 Million	-911,279 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.26 - $4.73 $71,299 - $103,449	-21,871 Reduced 2.34%	911,279 $3.09 Million
Q2 2020 Aug 14, 2020	SELL	$1.58 - $4.63 $134,379 - $393,781	-85,050 Reduced 8.35%	933,150 $4.31 Million
Q4 2019 Feb 14, 2020	BUY	$2.25 - $3.07 $2.29 Million - $3.13 Million	1,018,200 New	1,018,200 $2.79 Million
Q3 2019 Nov 14, 2019	SELL	$2.67 - $3.65 $715,405 - $977,988	-267,942 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$3.05 - $4.34 $324,236 - $461,372	106,307 Added 65.77%	267,942 $1.13 Million
Q4 2018 Feb 14, 2019	SELL	$2.82 - $4.67 $1.12 Million - $1.85 Million	-395,980 Reduced 71.01%	161,635 $503,000
Q3 2018 Nov 14, 2018	BUY	$1.45 - $6.15 $808,541 - $3.43 Million	557,615 New	557,615 $2.43 Million

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $185M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.